MANOLETE PARTNERS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.5 GBX | +1.79% |
|
-3.39% | -8.06% |
| Apr. 19 | Manolete Partners celebrates return to profit in financial 2024 | AN |
| Apr. 18 | AIM WINNERS & LOSERS: Surgical Innovations up as revenue jumps | AN |
Valuation
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 201.6 | 144.2 | 112.2 | 104.9 | 111.6 |
| Enterprise Value (EV) 1 | 173.7 | 118.3 | 88.66 | 82.47 | 98.26 |
| P/E ratio | 14.9 x | 19.5 x | 19.8 x | 30 x | -35.7 x |
| Yield | 0.32% | 1.06% | 0.84% | 0.37% | - |
| Capitalization / Revenue | 14.6 x | 7.72 x | 4.03 x | 5.13 x | 5.38 x |
| EV / Revenue | 12.6 x | 6.33 x | 3.19 x | 4.03 x | 4.73 x |
| EV / EBITDA | - | - | - | - | - |
| EV / FCF | 43.6 x | 26.5 x | 37.1 x | 19.5 x | -15.8 x |
| FCF Yield | 2.3% | 3.78% | 2.7% | 5.12% | -6.31% |
| Price to Book | 7.19 x | 4.13 x | 2.88 x | 2.48 x | 2.85 x |
| Nbr of stocks (in thousands) | 43,579 | 43,571 | 43,571 | 43,695 | 43,761 |
| Reference price 2 | 4.625 | 3.310 | 2.575 | 2.400 | 2.550 |
| Announcement Date | 7/5/19 | 7/3/20 | 5/30/21 | 6/23/22 | 6/20/23 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 10.63 | 13.77 | 18.68 | 27.83 | 20.44 | 20.75 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | 4.071 | 7.212 | 9.804 | 7.398 | 5.304 | -3.121 |
| Operating Margin | 38.3% | 52.37% | 52.48% | 26.58% | 25.95% | -15.04% |
| Earnings before Tax (EBT) 1 | 3.693 | 5.938 | 9.456 | 6.991 | 4.508 | -3.953 |
| Net income 1 | 3.261 | 4.664 | 7.615 | 5.7 | 3.678 | -3.124 |
| Net margin | 30.67% | 33.87% | 40.76% | 20.48% | 17.99% | -15.05% |
| EPS 2 | 32.74 | 0.3100 | 0.1700 | 0.1300 | 0.0800 | -0.0714 |
| Free Cash Flow 1 | 1.786 | 3.986 | 4.47 | 2.392 | 4.222 | -6.204 |
| FCF margin | 16.8% | 28.94% | 23.93% | 8.6% | 20.65% | -29.9% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | 54.77% | 85.46% | 58.7% | 41.97% | 114.8% | - |
| Dividend per Share | - | 0.0149 | 0.0350 | 0.0217 | 0.008900 | - |
| Announcement Date | 10/16/18 | 7/5/19 | 7/3/20 | 5/30/21 | 6/23/22 | 6/20/23 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2023 S1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | -4.441 |
| Net margin | - |
| EPS 2 | -0.1000 |
| Dividend per Share | - |
| Announcement Date | 11/10/22 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 7.62 | 27.9 | 25.9 | 23.5 | 22.4 | 13.3 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 1.79 | 3.99 | 4.47 | 2.39 | 4.22 | -6.2 |
| ROE (net income / shareholders' equity) | 53.2% | 26.1% | 24.2% | 15.4% | 9.07% | -7.68% |
| ROA (Net income/ Total Assets) | 17.3% | 17.5% | 15.5% | 8.85% | 5.27% | -2.98% |
| Assets 1 | 18.88 | 26.71 | 49.26 | 64.43 | 69.82 | 104.8 |
| Book Value Per Share 2 | 77.90 | 0.6400 | 0.8000 | 0.8900 | 0.9700 | 0.8900 |
| Cash Flow per Share 2 | 59.60 | 0.2200 | 0.1900 | 0.0300 | 0.0500 | 0.0100 |
| Capex | - | 0.45 | - | - | - | - |
| Capex / Sales | - | 3.25% | - | - | - | - |
| Announcement Date | 10/16/18 | 7/5/19 | 7/3/20 | 5/30/21 | 6/23/22 | 6/20/23 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.06% | 77.67M | |
| -.--% | 399M | |
| +25.49% | 251M | |
| -22.33% | 197M | |
| +12.56% | 134M |
- Stock Market
- Equities
- MANO Stock
- Financials Manolete Partners Plc
